Tiziano Barbui Selected Research

Busulfan (Busulfex)

12/2021	Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.
9/2015	Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tiziano Barbui Research Topics

Disease

51	Thrombosis (Thrombus) 01/2024 - 08/2002
49	Polycythemia Vera 06/2023 - 01/2003
41	Neoplasms (Cancer) 01/2024 - 10/2002
32	Essential Thrombocythemia 05/2024 - 05/2003
27	Primary Myelofibrosis (Myelosclerosis) 01/2024 - 01/2003
17	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 11/2002
13	Splenomegaly 12/2023 - 12/2007
12	Hemorrhage 07/2021 - 08/2002
10	Leukemia 01/2017 - 03/2002
9	Thrombocytosis (Thrombocythemia) 01/2024 - 08/2007
7	Pruritus (Itching) 01/2023 - 12/2007
6	COVID-19 01/2023 - 01/2021
6	Anemia 01/2020 - 01/2003
6	Thrombocytopenia (Thrombopenia) 12/2017 - 01/2003
6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2007 - 01/2003
5	Inflammation (Inflammations) 01/2023 - 02/2006
4	Disease Progression 01/2024 - 12/2005
4	Venous Thromboembolism 10/2021 - 03/2008
4	Polycythemia (Erythrocytosis) 10/2012 - 01/2003
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 01/2002
3	Leukocytosis (Pleocytosis) 04/2022 - 03/2007
3	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019 - 04/2004
3	Stroke (Strokes) 11/2018 - 01/2003
3	Pulmonary Embolism 01/2018 - 01/2004
3	Fibrosis (Cirrhosis) 02/2014 - 05/2009
3	Lymphoma (Lymphomas) 07/2013 - 10/2002
3	Residual Neoplasm 04/2009 - 02/2002
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2009 - 06/2005
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2008 - 02/2002
3	Infections 01/2007 - 10/2002
3	Multiple Myeloma 12/2005 - 01/2002
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2005 - 11/2002
2	Headache (Headaches) 01/2024 - 01/2002
2	von Willebrand Diseases (von Willebrand's Disease) 09/2021 - 07/2021
2	Systemic Mastocytosis 08/2019 - 01/2018
2	Pain (Aches) 02/2014 - 07/2013
2	Thrombophilia 12/2013 - 03/2008
2	Fatigue 07/2013 - 07/2011
2	Acute Promyelocytic Leukemia 03/2008 - 01/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2005 - 05/2003
2	Myocardial Infarction 01/2004 - 01/2003
2	Habitual Abortion (Recurrent Miscarriage) 04/2003 - 01/2003
2	Fetal Death 04/2003 - 01/2003
1	Paresthesia (Dysesthesia) 01/2024
1	Dizziness (Lightheadedness) 01/2024
1	Thyroiditis 01/2023

Drug/Important Bio-Agent (IBA)

29	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 08/2002
23	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 08/2002
20	ruxolitinibIBA 10/2022 - 03/2012
16	AnticoagulantsIBA 01/2022 - 11/2002
8	AntibodiesIBA 01/2023 - 11/2002
8	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2007
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2013
5	Janus Kinase 2IBA 01/2024 - 08/2007
5	Janus Kinase InhibitorsIBA 12/2023 - 12/2013
5	InterferonsIBA 12/2022 - 10/2012
5	Vitamin K FDA Link 01/2022 - 03/2008
5	Syntex adjuvant formulationIBA 12/2017 - 07/2011
5	Rituximab (Mabthera)FDA Link 07/2008 - 02/2002
5	Anticardiolipin AntibodiesIBA 08/2007 - 11/2002
5	Antiphospholipid AntibodiesIBA 08/2007 - 01/2003
4	CalreticulinIBA 01/2018 - 10/2014
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2007 - 01/2002
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2021 - 01/2003
3	C-Reactive ProteinIBA 04/2018 - 02/2011
3	Reticulin (Reticular Fiber)IBA 02/2014 - 05/2009
3	Protein CIBA 12/2013 - 04/2005
3	Prothrombin (Factor II)IBA 08/2007 - 11/2002
3	Immunoglobulin G (IgG)IBA 08/2007 - 03/2003
2	Busulfan (Busulfex)FDA Link 12/2021 - 09/2015
2	Interferon-alpha (Interferon Alfa)IBA 09/2021 - 09/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 03/2008
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2008
2	Dihydrotachysterol (AT 10)IBA 01/2019 - 08/2011
2	Janus KinasesIBA 12/2013 - 03/2012
2	givinostatIBA 06/2013 - 08/2010
2	Histone Deacetylase InhibitorsIBA 06/2013 - 08/2010
2	Thrombin FDA Link 04/2011 - 11/2008
2	Dalteparin (Dalteparin Sodium)FDA Link 01/2008 - 02/2006
2	CytokinesIBA 01/2008 - 07/2007
2	beta 2-Glycoprotein I (Apolipoprotein H)IBA 08/2007 - 10/2003
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2005 - 03/2002
2	Thalidomide (Thalomid)FDA Link 09/2004 - 01/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2002 - 01/2002
2	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2002 - 01/2002
1	Investigational DrugsIBA 01/2024
1	Thyroglobulin FDA Link 01/2023
1	ABO Blood-Group SystemIBA 01/2023
1	TESIBA 10/2022

Therapy/Procedure

59	Therapeutics 01/2024 - 01/2003
13	Drug Therapy (Chemotherapy) 04/2022 - 01/2002
6	Stem Cell Transplantation 12/2023 - 05/2007
4	Splenectomy 02/2014 - 01/2005
4	Autologous Transplantation 12/2005 - 01/2002
2	Perioperative Care 01/2024 - 01/2023
2	Contraindications 01/2023 - 01/2004
2	Transplantation 01/2023 - 01/2018
2	Liver Transplantation 06/2022 - 01/2018
2	Erythrocyte Transfusion 12/2017 - 01/2017
1	Cell Transplantation 01/2023